

Srini Pharmaceuticals Private Limited is a pharmaceutical manufacturing company operating regulated production facilities in India. To support its manufacturing and expansion requirements, the company partnered with Standard Engineering Technology (formally Standard Glass Lining Technology Limited) for the supply of glass lined equipment and associated spares suitable for GMP and CGMP environments.
The partnership began in June 2015, when Srini Pharmaceuticals required a reliable supplier capable of supporting a major project at its Vizag facility, including the Choutuppal unit. The client’s requirement focused on high quality glass lined equipment that could meet strict regulatory standards while delivering consistent performance in day to day pharmaceutical manufacturing. Timely project execution and dependable ongoing support were critical, as the equipment was required to align with planned production schedules and future operational needs.
Standard Engineering Technology supplied a range of GMP and CGMP MSGL equipment to support these requirements. The scope included glass lined reactors and related equipment designed to meet regulatory criteria for pharmaceutical processing. In addition to initial supply, Standard Engineering Technology also provided ongoing spares support to ensure continuity of operations at the Choutuppal unit. The supplied equipment was manufactured with careful attention to reactor finish, workmanship, and overall build quality to support long term use in a regulated environment.
Delivery was managed with a strong focus on meeting agreed timelines and maintaining quality throughout manufacturing and supply. The Vizag project was completed within the required timeframe, enabling smooth installation and commissioning without disruption to planned operations. Continued availability of spares further supported operational stability and reduced downtime risks following commissioning.
Following installation, the supplied glass lined equipment has been in continuous use at Srini Pharmaceuticals since 2015. Operational feedback confirms that the quality of the GMP and CGMP MSGL equipment has met required criteria, with particular recognition given to reactor finishing, workmanship, and overall performance. The equipment has demonstrated reliable operation under routine pharmaceutical manufacturing conditions, contributing to stable and compliant production processes.
The outcome of the project has been a positive and sustained supplier relationship. Srini Pharmaceuticals has confirmed satisfaction with both the quality and performance of the supplied equipment, as well as the reliability of ongoing service support. The successful delivery and long term operation of the equipment have reinforced confidence in Standard Engineering Technology as a trusted supplier for regulated pharmaceutical applications.
This project highlights the importance of combining manufacturing quality, regulatory understanding, and dependable project delivery when supporting pharmaceutical manufacturing operations. The continued performance of the equipment since 2015 demonstrates its suitability for demanding GMP and CGMP environments.
Readers are encouraged to view the official performance certificate issued by Srini Pharmaceuticals Private Limited to see independent confirmation of equipment quality, delivery performance, and client satisfaction.
